Epinephrine
Dilution requiredFull monograph review pending
Historical dilution reference. Verify the preparation against the label for the product in hand.
Original GlobalRPh article: Epinephrine (opens in a new tab)Original source URL: https://globalrph.com/dilution/epinephrine/ Retrieved 2026-11-04
Historical source details
Original publication date: unavailable in the retrieved article.
Source location and file checksums
- Original source URL
- https://globalrph.com/dilution/epinephrine/ (opens in a new tab)
- Source date
- Not established in the retrieved source
- Retrieved
- 2026-11-04T19:46:38.313662+00:00
- Source location
- div.post-content
- Packaged content SHA-256
- cbc6b045d985158fbe304a2a57b728461287ccedf1b7e09622710df4c6168178
- Original response SHA-256
- 6484c985c0a82de45b50d01c2cec75b438db30340bcc93b886221b85c037cdfa
- Source body SHA-256
- dd83b4834d7b3dc327660ba669088460bcab33b375cade354f2a7ed3a7bf2986
EPINEPHRINE |
| The authors make no claims of the accuracy of the information contained herein; and these suggested doses and/or guidelines are not a substitute for clinical judgment. Neither GlobalRPh Inc. nor any other party involved in the preparation of this document shall be liable for any special, consequential, or exemplary damages resulting in whole or part from any user's use of or reliance upon this material. PLEASE READ THE DISCLAIMER CAREFULLY BEFORE ACCESSING OR USING THIS SITE. BY ACCESSING OR USING THIS SITE, YOU AGREE TO BE BOUND BY THE TERMS AND CONDITIONS SET FORTH IN THE DISCLAIMER. |
Usual Diluents |
| NS, D5W |
Standard Dilutions [Amount of drug] [Infusion volume] [Infusion rate] |
| [1 to 5 mg] [250 ml] [Titrate]
Central line required for administration. |
Stability / Miscellaneous |
| EXP: 1 DAY (RT).
Dosing: Cardiac arrest: 0.5 to 1 mg bolus (1:10,000) q5min prn. May give 0.3 mg SC or start continuous infusion (range: 1 to 10 mcg/min). Calculation of drip rate (ml/hr) -------------------------------------------------------------------------------- Dosing (Adults): Intratracheal: Administer 2-2.5 times the recommended I.V. dose; dilute in 10 mL NS or distilled water. Note: Absorption is greater with distilled water, but causes more adverse effects on PaO2. Bronchodilator: I.M., SubQ ( 1:1000 ): 0.1-0.5 mg every 10-15 minutes to 4 hours Hypersensitivity reaction: I.M., SubQ: 0.3-0.5 mg every 15-20 minutes if condition requires; if hypotension is present: 0.1 mg I.V. slowly over 5-10 minutes followed by continuous infusion 1-10 mcg/minute Symptomatic bradycardia or heart block (not responsive to atropine or pacing): I.V. infusion: 1-10 mcg/minute; titrate to desired effect Refractory hypotension (refractory to dopamine/dobutamine): Continuous I.V. infusion 1 mcg/minute (range: 1-10 mcg/minute); titrate dosage to desired effect; severe cardiac dysfunction may require doses >10 mcg/minute (up to 0.1 mcg/kg/minute) Nebulization: Instill 8-15 drops into nebulizer reservoirs; administer 1-3 inhalations 4-6 times/day Administration Epinephrine can be administered SubQ, I.M., I.V., or intracardiac injection I.M. administration into the buttocks should be avoided Preparation of adult I.V. infusion: Dilute 1 mg in 250 mL of D5W or NS (4 mcg/mL); administer at an initial rate of 1 mcg/minute and increase to desired effects; at 20 mcg/minute pure alpha effects occur Extravasation management: Use phentolamine as antidote. Mix 5 mg with 9 mL of NS. Inject a small amount of this dilution into extravasated area. Blanching should reverse immediately. Monitor site. If blanching should recur, additional injections of phentolamine may be needed. Stability Oxidation turns drug pink, then a brown color; solutions should not be used if they are discolored or contain a precipitate. Stability of injection of parenteral admixture at room temperature (25°C) or refrigeration (4°C): 24 hours. Standard diluent: 1 mg/250 mL NS. Source: [package insert] |
U.S. label preparation
Epinephrine 1 mg/mL vial · Dilution required
- Preparation
- For the adult septic-shock IV infusion in this label, dilute 1 mg in 1,000 mL of 5% dextrose or a sodium chloride solution containing 5% dextrose. The labeled concentration is 1 mcg/mL.
- Administration and handling
- Titrate the infusion to the prescribed blood pressure goal. Use the separate route-specific directions for anaphylaxis.
Product and source details
Amneal Pharmaceuticals LLC · ANDA217485
Product NDC: 70121-1660
SPL effective 2025-10-31 | SPL version 5. Checked 2026-11-13.
Source for this summary: U.S. prescribing information. Use the full label for dose selection, contraindications, preparation tables and monitoring.
Safety resources for this medication (1)
Read the linked communication and current prescribing information before use. Resource dates and affected product scopes differ; a listed resource is not a full monograph or a lot-specific clearance.
Product identifiers and clinical review status
U.S. label preparation available. Full monograph review pending.
Exact formulation, concentration, container, manufacturer, regulatory identifiers, and a reproducible label snapshot have not all been reconciled.
What remains to be completed
- Obtain independent corroboration of the label preparation where available.
- Complete indication- and age-specific dosing, incompatibility, monitoring and stability review.
- Assess any proposed compounding BUD for the exact formulation, concentration, container and conditions.
Open the original GlobalRPh site monograph (historical; not revalidated) (opens in a new tab)